Overview

Varenicline for Adolescent Smoking Cessation

Status:
Completed

Trial end date:
2018-01-26

Target enrollment:

Participant gender:

Summary

This is a placebo-controlled smoking cessation treatment study for adolescents ages 14-21. After assessment and inclusion into the study, participants will be randomized to receive a 12-week double blind course of varenicline or placebo.

Phase:

Phase 3

Details

Lead Sponsor:

Medical University of South Carolina

Treatments:

Varenicline